| Sue Chang, MD | |
|
136 Sherman Ave, Suite 405, New Haven, CT 06511-5238 | |
| (203) 787-0117 | |
| (203) 777-3559 |
| Full Name | Sue Chang |
|---|---|
| Gender | Female |
| Speciality | Nephrology |
| Experience | 34 Years |
| Location | 136 Sherman Ave, New Haven, Connecticut |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1528054848 | NPI | - | NPPES |
| 001346916 | Medicaid | CT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | 34691 (Connecticut) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| U.s.renal Care Orange Dialysis | Orange, CT | Dialysis facility |
| Yale-new Haven Hospital | New haven, CT | Hospital |
| Bridgeport Hospital | Bridgeport, CT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Metabolism Associates Pc | 2668466244 | 11 |
News Archive
A protein known to be involved in a rare hereditary cancer syndrome may have a role in the regulation of liver stem cells and the development of liver cancer. In the August 15 issue of Genes & Development, a Massachusetts General Hospital (MGH) research team describes finding that the protein called merlin, encoded by the NF2 (neurofibromatosis type 2) gene, controls the activity of adult stem cells that give rise to the two major types of liver cells.
There may be new treatments for stroke, migraine, Alzheimer's and other brain disorders, thanks to the discovery of a mechanism for regulating brain blood flow made by researchers at the University of British Columbia.
The National Institutes of Health announced today that it is awarding 15 new grants to further develop and test the Patient Reported Outcomes Measurement Information System (PROMIS).
Miracor Medical Systems GmbH announced today the successful completion of the pilot study of its PICSO System, designed to improve acute coronary syndrome revascularization following primary percutaneous coronary intervention.
› Verified 9 days ago
| Entity Name | Yale University |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205822236 PECOS PAC ID: 9436061736 Enrollment ID: O20031105000015 |
News Archive
A protein known to be involved in a rare hereditary cancer syndrome may have a role in the regulation of liver stem cells and the development of liver cancer. In the August 15 issue of Genes & Development, a Massachusetts General Hospital (MGH) research team describes finding that the protein called merlin, encoded by the NF2 (neurofibromatosis type 2) gene, controls the activity of adult stem cells that give rise to the two major types of liver cells.
There may be new treatments for stroke, migraine, Alzheimer's and other brain disorders, thanks to the discovery of a mechanism for regulating brain blood flow made by researchers at the University of British Columbia.
The National Institutes of Health announced today that it is awarding 15 new grants to further develop and test the Patient Reported Outcomes Measurement Information System (PROMIS).
Miracor Medical Systems GmbH announced today the successful completion of the pilot study of its PICSO System, designed to improve acute coronary syndrome revascularization following primary percutaneous coronary intervention.
› Verified 9 days ago
| Entity Name | Metabolism Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861473787 PECOS PAC ID: 2668466244 Enrollment ID: O20040414001492 |
News Archive
A protein known to be involved in a rare hereditary cancer syndrome may have a role in the regulation of liver stem cells and the development of liver cancer. In the August 15 issue of Genes & Development, a Massachusetts General Hospital (MGH) research team describes finding that the protein called merlin, encoded by the NF2 (neurofibromatosis type 2) gene, controls the activity of adult stem cells that give rise to the two major types of liver cells.
There may be new treatments for stroke, migraine, Alzheimer's and other brain disorders, thanks to the discovery of a mechanism for regulating brain blood flow made by researchers at the University of British Columbia.
The National Institutes of Health announced today that it is awarding 15 new grants to further develop and test the Patient Reported Outcomes Measurement Information System (PROMIS).
Miracor Medical Systems GmbH announced today the successful completion of the pilot study of its PICSO System, designed to improve acute coronary syndrome revascularization following primary percutaneous coronary intervention.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sue Chang, MD 136 Sherman Ave, Suite 405, New Haven, CT 06511-5238 Ph: (203) 787-0117 | Sue Chang, MD 136 Sherman Ave, Suite 405, New Haven, CT 06511-5238 Ph: (203) 787-0117 |
News Archive
A protein known to be involved in a rare hereditary cancer syndrome may have a role in the regulation of liver stem cells and the development of liver cancer. In the August 15 issue of Genes & Development, a Massachusetts General Hospital (MGH) research team describes finding that the protein called merlin, encoded by the NF2 (neurofibromatosis type 2) gene, controls the activity of adult stem cells that give rise to the two major types of liver cells.
There may be new treatments for stroke, migraine, Alzheimer's and other brain disorders, thanks to the discovery of a mechanism for regulating brain blood flow made by researchers at the University of British Columbia.
The National Institutes of Health announced today that it is awarding 15 new grants to further develop and test the Patient Reported Outcomes Measurement Information System (PROMIS).
Miracor Medical Systems GmbH announced today the successful completion of the pilot study of its PICSO System, designed to improve acute coronary syndrome revascularization following primary percutaneous coronary intervention.
› Verified 9 days ago
Dr. Brian Christopher Cambi, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 333 Cedar St, Dcb 3, New Haven, CT 06510 Phone: 203-785-4129 Fax: 203-737-2437 | |
Ms. Maryam Gondal, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 330 Cedar Street, Bb 114, New Haven, CT 06510 Phone: 203-785-4184 | |
Matthew Joseph Mcconnell, M.D. Nephrology Medicare: Medicare Enrolled Practice Location: 333 Cedar St, Ynhh Internal Medicine-gi,section Of Digestive Diseases, New Haven, CT 06510 Phone: 203-785-7012 | |
Marie Anjeliese Rodriguez, Nephrology Medicare: Medicare Enrolled Practice Location: 20 York St, New Haven, CT 06510 Phone: 203-688-4242 | |
Dr. Margaret M Xu, MD Nephrology Medicare: Medicare Enrolled Practice Location: 20 York St, New Haven, CT 06510 Phone: 203-688-4242 | |
Carola Marte, MD Nephrology Medicare: Not Enrolled in Medicare Practice Location: 1450 Chapel St, Haelen Center, New Haven, CT 06511 Phone: 203-789-4135 Fax: 203-867-5241 | |
Jeanette M Tetrault, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1 Long Wharf Dr, New Haven, CT 06511 Phone: 203-781-4600 Fax: 203-781-4624 |